Study the immunological status for COVID-19 patients

Authors

May Yahya Al- Ma’amouri, Department of Medical Laboratories Techniques, Institute of Medical Technology/Al-Mansour, Middle Technical University, IraqFollow
Mohammed Jasim Shaker, Department of microbiology, College of Medicine, Diyala University.Follow

Document Type

Original Study

Abstract

In the second half of 2019 a sort of sever pneumonia with unknown etiology was developed that extended to all over the word with rapid spread named 2019 Novel Coronavirus. viral infection ability to produce an extensive immune reaction in the host which associated with increase concentrations of pro-inflammatory cytokines/chemokine’s. They study aimed to evaluate the immunological state of covid patients which is reflected with concentrations level of tumor markers and interleukins.

Material and method: case control study include 60 patient, 30 control to evaluate the blood sugar, IL-6, IL-7, CEA, and CA19-9

Result: statistical significant differences were found in the mean level of sugar, IL-6 and CEA in covid patient group in compare to control group, with, p-value 0.0002, 0.0004 and 0.004.

Conclusion: covid infection will cause an increase in the concentration level of interleukins and tumor markers that related mainly to tissue damage.

Keywords

immunity, COVID-19, tissue damage, Coronavirus.

Recommended Citation

Al- Ma’amouri, May Yahya and Shaker, Mohammed Jasim (2024) "Study the immunological status for COVID-19 patients," Al-Qadisiyah Journal of Pure Science: Vol. 29 : No. 2 , Article 16.
Available at: https://doi.org/10.29350/2411-3514.1295

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.